| Sleep Enhancement Training Study for Novice Shiftworkers (NCT00786266) | University of California, San Francisco | 2008-11-01 |
| Efficacy of Dark Chocolate in Achalasia Patients (NCT00790465) | Tel-Aviv Sourasky Medical Center | 2008-11-01 |
| Bioequivalence Study On Pediatric Appropriate Formulation (NCT00777517) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-11-01 |
| Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) (NCT00947388) | Case Comprehensive Cancer Center | 2008-11-01 |
| Radioimmunoimaging of AL Amyloidosis (NCT01409148) | University of Tennessee | 2008-11-01 |
| Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU (NCT00770978) | Basilea Pharmaceutica | 2008-11-01 |
| A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED) (NCT01104545) | Merck Sharp & Dohme LLC | 2008-11-01 |
| Determination of Absorption and Elimination of Lamotrigine-XR (NCT00789113) | University of Minnesota | 2008-11-01 |
| ALK29-002: A Study of Baclofen Formulations in Healthy Adults (NCT00802035) | Alkermes, Inc. | 2008-11-01 |
| Staccato Loxapine Pulmonary Safety in Healthy Volunteers (NCT00789360) | Alexza Pharmaceuticals, Inc. | 2008-11-01 |
| Study Evaluating The Excretion Of Moxidectin Into The Breast Milk Of Lactating, Non-Breastfeeding Women (NCT00751764) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-11-01 |
| Antiviral Activity of AZD7295 in HCV Carriers (NCT00781976) | Arrow Therapeutics | 2008-11-01 |
| Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20 (NCT00803972) | Halozyme Therapeutics | 2008-11-01 |
| SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma (NCT00787527) | M.D. Anderson Cancer Center | 2008-11-01 |
| Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers (NCT00738751) | H. Lee Moffitt Cancer Center and Research Institute | 2008-11-01 |
| A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy (NCT00809419) | NeoVista | 2008-11-01 |
| Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017 (NCT00791752) | AstraZeneca | 2008-11-01 |
| Sorafenib-RT Treatment for Liver Metastasis (SLIM) (NCT00892424) | University Health Network, Toronto | 2008-11-01 |
| Development of a New Method for Analgesia (NCT00791024) | Ove Andersen | 2008-11-01 |
| A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye. (NCT00784719) | Pfizer | 2008-11-01 |
| Insulin Balanced Infusion System (NCT01291719) | Admetsys Corporation | 2008-11-01 |
| Radioimmunotherapy With 131I-L19SIP in Patients With Cancer (NCT01242943) | Philogen S.p.A. | 2008-11-01 |
| Phase 1 Norwalk Vaccine Study (NCT00806962) | LigoCyte Pharmaceuticals, Inc. | 2008-11-01 |
| Loperamide Grapefruit Juice Interaction PK Trial (NCT00806299) | Johnson & Johnson Consumer and Personal Products Worldwide | 2008-11-01 |
| Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia (NCT00838240) | European Organisation for Research and Treatment of Cancer - EORTC | 2008-11-01 |
| A Study of LY2584702 in Participants With Advanced Cancer (NCT01394003) | Eli Lilly and Company | 2008-11-01 |
| Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously (NCT00783341) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-11-01 |
| ATX-101 Abdominoplasty (NCT00835952) | Kythera Biopharmaceuticals | 2008-11-01 |
| Transplant of Epithelium Conjunctival Human Autologous Cultivated ex Vivo in Amniotic Membrane for the Treatment of Symblepharon (NCT00799526) | Federal University of São Paulo | 2008-11-01 |
| Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment (NCT00800150) | City of Hope Medical Center | 2008-11-01 |
| Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers (NCT00797706) | Kringle Pharma Europe AB | 2008-11-01 |
| Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living (NCT00878085) | Medical College of Wisconsin | 2008-11-01 |
| A Study To Investigate How The Body Handles Multiple Doses Of PF-0243873 And To Investigate The Effect Of PF-02413873 On Sex Hormone Levels In Healthy Young Women (NCT00800618) | Pfizer | 2008-11-01 |
| Safety and Efficacy of LCL161 in Patients With Solid Tumors (NCT01098838) | Novartis Pharmaceuticals | 2008-11-01 |
| AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian Subjects (NCT00785915) | AstraZeneca | 2008-11-01 |
| Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured (NCT00798629) | H. Lee Moffitt Cancer Center and Research Institute | 2008-11-01 |
| Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors (NCT00796484) | Exelixis | 2008-11-01 |
| Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy (NCT00910325) | Massachusetts General Hospital | 2008-11-01 |
| Single Dose Pharmacokinetics of Egalet® Hydrocodone (NCT00802087) | Egalet Ltd | 2008-11-01 |
| Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer (NCT01044485) | Centre Georges Francois Leclerc | 2008-11-01 |
| A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors. (NCT00773526) | Hoffmann-La Roche | 2008-11-01 |
| Sleep Enhancement Training Study for Experienced Shiftworkers (NCT00786357) | University of California, San Francisco | 2008-11-01 |
| Pilot Study to Assess Safety/Prelimary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery (NCT00798239) | BioSurface Engineering Technologies, Inc | 2008-11-01 |
| Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant (NCT00909948) | Massachusetts General Hospital | 2008-11-01 |
| Safety, Tolerability and Pharmacokinetics of BI 653048 H3PO4 Oral Drinking Solution in Healthy Male Volunteers (NCT02217644) | Boehringer Ingelheim | 2008-11-01 |
| Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine (NCT00900237) | Bial - Portela C S.A. | 2008-11-01 |
| Treatment of Atrophic Nonunion by Preosteoblast Cells (NCT00916981) | Jean-Philippe Hauzeur | 2008-11-01 |
| Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period (NCT00723983) | NuPathe Inc. | 2008-11-01 |
| Effects of Breathing Retraining in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01175265) | University Hospital, Essen | 2008-11-01 |
| A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function (NCT00759564) | Pfizer | 2008-11-01 |
| Effects of Multiple Doses of CS-8080 in Healthy Volunteers (NCT00796575) | Daiichi Sankyo | 2008-11-01 |
| Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer (NCT00828074) | City of Hope Medical Center | 2008-11-01 |
| Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia (NCT00788164) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-11-01 |
| Bioburden Reduction of Diabetic Foot Ulcer (NCT00776854) | Nomir Medical Technologies | 2008-11-01 |
| Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion (NCT00810212) | Mesoblast, Ltd. | 2008-11-01 |
| A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors (NCT00783328) | Pfizer | 2008-11-01 |
| A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients (NCT00801255) | Hoffmann-La Roche | 2008-11-01 |
| Effect of Calcium on Gleevec Pharmacokinetics (PK) in Healthy Volunteers (NCT00732784) | Jan Beumer | 2008-11-01 |
| Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration (NCT00793702) | Statens Serum Institut | 2008-11-01 |
| Effect of Calcium on Tasigna Pharmacokinetics (PK) in Healthy Volunteers (NCT00732888) | Jan Beumer | 2008-11-01 |
| A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) (NCT00442611) | Stanford University | 2008-11-01 |
| Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors (NCT00794131) | Genelux GmbH | 2008-11-01 |
| A Single Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers (NCT00799006) | Pfizer | 2008-11-01 |
| Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers (NCT00813670) | Xenon Pharmaceuticals Inc. | 2008-11-01 |
| Pharmacokinetic, Pharmacodynamic and Safety Evaluation After Single Oral Administration of KRN1493 (NCT00952094) | Seoul National University Hospital | 2008-11-01 |
| Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer (NCT00924287) | National Cancer Institute (NCI) | 2008-11-01 |
| To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake (NCT00829140) | Eisai Inc. | 2008-11-01 |
| Hydroxychloroquine and Gefitinib to Treat Lung Cancer (NCT00809237) | National University Hospital, Singapore | 2008-11-01 |
| Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of Moxidectin (NCT00736697) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-11-01 |
| Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously (NCT00788294) | Pfizer | 2008-11-01 |
| Intravenous Gammaglobulin for Sickle Cell Pain Crises (NCT01757418) | Albert Einstein College of Medicine | 2008-11-01 |
| AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer (NCT00770848) | Amgen | 2008-11-01 |
| Nutritional Intervention for Age-related Muscular Function and Strength Losses (NCT00874575) | Metabolic Technologies Inc. | 2008-11-01 |
| Single Dose of pGM169/GL67A in CF Patients (NCT00789867) | Imperial College London | 2008-11-01 |
| Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) (NCT00792857) | OPKO IP Holdings II, Inc. | 2008-11-01 |
| Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT00777894) | Swiss Cancer Institute | 2008-11-01 |
| Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors (NCT00884676) | Jaime Merchan | 2008-11-01 |
| Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer (NCT00895323) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 2008-11-01 |
| Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects (NCT00916110) | Ablynx, a Sanofi company | 2008-11-01 |
| Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia (NCT00924170) | National Cancer Institute (NCI) | 2008-10-31 |
| Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer (NCT00699491) | National Cancer Institute (NCI) | 2008-10-31 |
| A Safety Study of ARRY-371797 in Healthy Subjects (NCT00790049) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2008-10-31 |
| A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies (NCT00730639) | Bristol-Myers Squibb | 2008-10-30 |
| Computer-Assisted Self-Administration of Ethanol (NCT00713492) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2008-10-29 |
| Phase I Comparative Bioavailability Study (NCT00777582) | AstraZeneca | 2008-10-27 |
| Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) (NCT00788957) | NantBioScience, Inc. | 2008-10-27 |
| Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis (NCT00771030) | Amgen | 2008-10-27 |
| A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®) (NCT00739453) | Astellas Pharma Inc | 2008-10-23 |
| A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer (NCT01216176) | Joyce Marie Slingerland, MD | 2008-10-21 |
| A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By Injection (NCT00711126) | GlaxoSmithKline | 2008-10-21 |
| First Time in Human Study (FTIH) With Positron Emission Tomography (PET) (NCT01381419) | GlaxoSmithKline | 2008-10-20 |
| Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes (NCT00708604) | City of Hope Medical Center | 2008-10-18 |
| A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248) (NCT00779584) | Merck Sharp & Dohme LLC | 2008-10-17 |
| ARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular Degeneration (NCT00709527) | Ophthotech Corporation | 2008-10-16 |
| Vaccine for Prevention of Bird Flu (NCT00776711) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-16 |
| Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer (NCT00789776) | Fred Hutchinson Cancer Center | 2008-10-13 |
| Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC) (NCT00745732) | M.D. Anderson Cancer Center | 2008-10-09 |
| A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma (NCT00743496) | St. Jude Children's Research Hospital | 2008-10-08 |
| Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function (NCT00674024) | National Cancer Institute (NCI) | 2008-10-07 |
| Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers (NCT00780182) | Jazz Pharmaceuticals | 2008-10-01 |